Literature for peptidase S01.133: cathepsin G

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2017
1. Khan,M., Carmona,S., Sukhumalchandra,P., Roszik,J., Philips,A., Perakis,A.A., Kerros,C., Zhang,M., Qiao,N., John,L.S.S., Zope,M., Goldberg,J., Qazilbash,M., Jakher,H., Clise-Dwyer,K., Qiu,Y., Mittendorf,E.A., Molldrem,J.J., Kornblau,S.M. and Alatrash,G.
   Cathepsin G is expressed by acute lymphoblastic leukemia and is a potential immunotherapeutic target
   Front Immunol8, 1975-1975. PubMed  Europe PubMed DOI  T
2013
2. Alatrash,G.
   Targeting cathepsin G in myeloid leukemia
   Oncoimmunology2, e23442-e23442. PubMed  Europe PubMed DOI  T
2010
3. Korkmaz,B., Horwitz,M.S., Jenne,D.E. and Gauthier,F.
   Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases
   Pharmacol Rev62, 726-759. PubMed  Europe PubMed DOI  V  T
2009
4. Wilson,T.J., Nannuru,K.C. and Singh,R.K.
   Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1
   Cancer Res69, 3188-3195. PubMed  Europe PubMed DOI  T
2007
5. Shimoda,N., Fukazawa,N., Nonomura,K. and Fairchild,R.L.
   Cathepsin G is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys
   Am J Pathol170, 930-940. PubMed  Europe PubMed DOI  T